Do answers to the mysteries of cancer lie hidden within the DNA of tumor cells? Researchers think so.
Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.
Novartis is one of this year’s top 20 employers in an annual survey from Science.
Emerging markets in Africa are gearing up for clinical research. Learn how Novartis is working with Ghana and Kenya to build research capacity.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.